Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program

    NEXT STORY
    Nevada Gold Mines Provides Covid-19 Support for Local Communities
    PREV STORY
    Dynavax Provides Business Update on COVID-19 Pandemic Impact
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    The fluoroscopy equipment market is projected to reach USD 7.11 billion by 2024 from USD 5.75 billion in 2019, at a CAGR of 4.4%

    author_avatar
    NASDAQ Market News

    ISC® Provides STARS With Saskatchewan Geographic Data to Aid Emergency Response

    author_avatar
    NASDAQ Market News

    BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements

    author_avatar
    NASDAQ Market News